Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs715320-   
Low Rs397231-   
Sales per share (Unadj.) Rs424.295.1-  
Earnings per share (Unadj.) Rs32.9-24.0-  
Cash flow per share (Unadj.) Rs54.1-19.9-  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.174.6-  
Shares outstanding (eoy) m585.94168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.9 45.3%   
Avg P/E ratio x16.9-11.5 -147.2%  
P/CF ratio (eoy) x10.3-13.9 -74.1%  
Price / Book Value ratio x1.23.7 32.9%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,75346,446 701.4%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m35,2232,915 1,208.3%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m248,55416,052 1,548.4%  
Other income Rs m2,906112 2,585.1%   
Total revenues Rs m251,46016,165 1,555.6%   
Gross profit Rs m37,070-2,782 -1,332.6%  
Depreciation Rs m12,446693 1,796.4%   
Interest Rs m1,405435 323.1%   
Profit before tax Rs m26,125-3,797 -688.0%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,849237 2,886.5%   
Profit after tax Rs m19,277-4,045 -476.6%  
Gross profit margin %14.9-17.3 -86.1%  
Effective tax rate %26.2-6.2 -419.5%   
Net profit margin %7.8-25.2 -30.8%  
BALANCE SHEET DATA
Current assets Rs m214,59911,757 1,825.3%   
Current liabilities Rs m114,9386,615 1,737.5%   
Net working cap to sales %40.132.0 125.2%  
Current ratio x1.91.8 105.1%  
Inventory Days Days21111 18.6%  
Debtors Days Days66124 52.9%  
Net fixed assets Rs m176,6686,853 2,577.9%   
Share capital Rs m58675 786.1%   
"Free" reserves Rs m267,8130-   
Net worth Rs m268,39912,599 2,130.3%   
Long term debt Rs m6,1904,428 139.8%   
Total assets Rs m392,12523,801 1,647.5%  
Interest coverage x19.6-7.7 -253.4%   
Debt to equity ratio x00.4 6.6%  
Sales to assets ratio x0.60.7 94.0%   
Return on assets %5.3-15.2 -34.8%  
Return on equity %7.2-32.1 -22.4%  
Return on capital %10.0-19.8 -50.6%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Net fx Rs m44,0360-   
CASH FLOW
From Operations Rs m23,8681,370 1,741.9%  
From Investments Rs m-39,778-421 9,454.8%  
From Financial Activity Rs m18,1444,018 451.5%  
Net Cashflow Rs m2,2984,968 46.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare AUROBINDO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: BROOKS LAB  ZENITH HEALTH  SMRUTHI ORGANICS  ANUH PHARMA  EARUM PHARMACEUTICALS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.